Cardiomyopathies Flashcards

(37 cards)

1
Q

3 Main categories

A
  1. Dilated (MC)
  2. Hypertrophic (HT CM #1 cause sudden death athletes)
  3. Restrictive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dilated pathophysiology

A

Dilated ventricles, no hypertrophy.
Systolic failure, EDV & ESV increase, LVEF decreases.
Dilation worsens due to increased volume blood.
May cause mitral/tricuspid regurgitation-worsens CO.
S/s due to back up of blood or decreased CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dilated causes

A
Alcohol
Beriberi
Coxsackie B/Chagas
Drugs
Pregnancy
Idiopathic (50%)/Infection
Genetic

Interstitial/Endocardial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ischemic dilated CM

A

MCC of dilated CM.
MCC of systolic HF.
LVEF<35-40% from CAD.
Tx: same + CAD tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HTN dilated CM

A

Concentric LVH–Dilation–Eccentric remodeling

With Systolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alcoholic dilated CM

A

Mechanism: unclear, Acetaldehyde–myocardial depression
>90g (7-8 drinks) for >5 years
Increased QTc due to decreased Mg/K
Tx: Abstinence, will improve outcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Peripartum dilated CM

A

When? Late preg (after 36 wks) & w/in 5 mo of birth
Risk factors: AA, >30yo, Cocaine, Multiple fetus, Ecclampsia/Pre.
Tx: transplant 1/3. If LVEF >50% 6mo., can wean off tx.
Mortality: 10% in 2 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Takotsubo dilated CM

A

Transient decreased LVEF
Systolic apical ballooning on echo (hyperkinesis in upper walls, apex balloons)
Sx: CP, Trop increased, ST elevation. NO CAD.
Cause: stress, catelcholamines, post-menopausal
Recovery: 1-4 weeks, increased risk for arrhythmia/shock.
Recurrence: beta-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dilated CM clinical presentation

A

Age 20-60, but any age
HF sx: dyspnea, JVD, peripheral edema, congestive cough with white sputum.
Misdx: Viral URI in younger population.
Hx: Breast cancer chemo, thyroid, drug use, family hx of sudden cardiac death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dilated CM PE signs

A
  1. HF signs (Hepatojug reflux/JVD/crackles/clubbing)
  2. PMI shifted left
  3. S3 gallop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dilated CM Dx test

A
  1. Labs: CBC (anemia), CMP (hyponatremia=poor prognosis), Thyroid, Biomarkers/BNP, Urine drug if suspicious
  2. CXR: cardiomegaly, Kerley B, R pleural effusion, congestion
  3. EKG: LVH, arrhythmias, conduction delay
  4. Cath: R/O ischemic cause
  5. Biopsy: limited use, for amyloid/sarcoid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dilated CM medical tx

A
  1. ACE/ARB + Diuretic/Aldosterone ant. + Beta-blocker
  2. ARNI
  3. Inotropes for end-stage
  4. Anticoag for AFib
  5. Nitrates for sx relief
  6. Revascularize if ischemic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dilated CM surgical tx

A
  1. LVAD
  2. CRT (resynchronization): LVEF<35, BBB, pers HF sx
  3. AICD (cardiovert/defib): At risk for ventricular arrhythmias
  4. Transplant: Dilated CM=45% of transplants in US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypertrophic CM etiology

A
1. Familial HCM (50-60%)
Genetic, Autosomal dominant mutation of sarcomere
2. Septum abnormalities
3. Subendocardial ischemia
4. Abnormal SNS 
5. Ab thick intramural coronary aa.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypertrophic CM epidemiology

A

0.5% population (1/200 adults)
M>F, F present younger
MC in 3rd decade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Obstructive HCM physiology

A

LVOTO: left ventricular outflow tract obstruction
SAM: systolic anterior motion of mitral valve toward septum. Can lead to mitral regurg.
Worse: with decreased preload/afterload & increase inotropy due to ventricle not being as large
Better: with increased preload/afterload. Ventricle more open.

17
Q

LVOTO murmur & maneuvers/factors

A

Systolic crescendo-decrescendo
Between apex & LSB
1. INCREASE with DECREASE preload/afterload or INCREASE contractility
Valsalva, Standing, Dehydration, Dihydropyridines, Fever, Amyl Nitrate, Dobutamine
2. DECREASE with INCREASE preload/afterload
Squatting, Hand grip, Supine w/legs up, Nondihydro, Beta blocker.

18
Q

Nonobstructive HCM pathophysiology

A

Decreased ventricle size, Decreased diastolic filling=Diastolic failure
Which decreases the outflow/CO

19
Q

HCM risks

A

SVT/VT

SCD (sudden cardiac death)-risk stratify to see if they need an ICD.

20
Q

Risk factors for SCD

A
  1. Hx of syncope
  2. Family hx of sudden death
  3. Abnormal BP response to exercise
  4. LV wall >30mm
  5. Vtach
  6. <30 y.o.
  7. Hx of survived cardiac arrest
21
Q

HCM progression

A

Most asx. Children more sx early on (higher risk SCD)

10-15% progress to DCM-Slow clinically.

22
Q

HCM sx

A
Syncope
Palpitations
Orthopnea/PND/Dyspnea
Dizzy
Angina
23
Q

HCM PE findings

A
  1. S4
  2. Double apical pulse (due to LA forceful contraction)
  3. Murmur
  4. S2 splitting in severe LVOTO
24
Q

HCM Dx

A
  1. Dx= Transthoracic Echo
  2. Exercise test for BP response
  3. Ambulatory EKG for arrhythmias
25
HCM management (nonpharm)
1. Risk stratify for ICD 2. Limit physical activity 3. Avoid volume depletion (decreases preload)
26
HCM medical tx
1. Beta-blocker (negative inotropy, increase fill time) 2. Nondihydro CCB (MUST D/C BB) Use if BB not effective. Careful for: vasodilation, sinus arrest, pulmonary edema, AV node block 3. Disopyramide (1a anti-arrhythmic) Use in conjunction with BB or CCB if sx on monotherapy. Negative inotrope (Increase QTc, AV node, anticholinegric) Dont use for BPH.
27
HCM surgical options
1. Septal myectomy. Can repair MV at same time. | 2. Alcohol septal ablation. Local MI at SAM area.
28
Restrictive CM Etiology
1. Primary=idiopathic (Endomyocardial fibrosis/Loeffler) 2. Secondary=other ds causes Amyloidosis (#1 US cause) Sarcoidosis, Scleroderma, Metastasis, Radiation, Drug (chloroquine), Hematochromatosis
29
Restrictive CM Epidemiology
F=M, Children worse prognosis Genetic link. Loeffler=worldwide Amyloidosis=US
30
Restrictive CM pathophysiology
1. Infiltration decreases ventricular compliance 2. Increase ventricular pressure 3. Reduced V filling, decreases CO 4. Pressure backs up into atria=Bi-atrial enlargement
31
Restrictive CM clinical presentation
Late, with dyspnea, orthopnea, fatigue Palpitations-often causes AFib Thromboembolic events Orthostatic hypotension/syncope (Amyloidosis with Neuropathy)
32
Restrictive CM PE findings
1. Kussmauls sign 2. R HF: JVP, pleural effusion,etc 3. Cardiac cachexia 4. Amyloidosis: bruising, periorbital purpura, macroglossia
33
Restrictive CM Dx imaging
1. Echo: Infiltrative=LVH, septal/valve thickening 2. Cardiac MRI: LGE pattern (global subendocardial late gad. enhancement) (May do Cath/Biopsy)
34
Restrictive CM lab tests
1. CBC w/smear-Eosinophilia 2. CMP-kidney/liver fxn 3. Iron/Ferritin/TIBC 4. BNP (NOT increased in pericarditis)
35
Restrictive CM EKG changes
1. Low voltage QRS 2. AFib common 3. May see ST depression
36
Restrictive CM medical tx
1. Beta blocker 2. Nondihydro CCB (both increase fill time) 3. Diuretic (decrease preload but careful!) 4. Anticoag AFib Amyloidosis: NO ACE/ARB, hypotension due to neuropathy
37
Restrictive CM management non pharm
1. Amyloidosis=chemo, Sarcoidosis=corticosteroids, Hematochromatosis=phleb/chelation 2. Pacemaker if AV/SA node fibrosis causing heart block 3. LVAD/transplant